(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-02 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 169991
Date | Daily Closing Price | Open | High | Low | Volume |
02 Fri Aug 2024 | 7.33 | 7.37 | 7.44 | 6.98 | 1.414 times |
01 Thu Aug 2024 | 7.40 | 7.75 | 7.75 | 7.20 | 1.018 times |
31 Wed Jul 2024 | 7.75 | 7.61 | 7.87 | 7.51 | 0.768 times |
30 Tue Jul 2024 | 7.61 | 8.00 | 8.06 | 7.56 | 0.758 times |
29 Mon Jul 2024 | 8.00 | 8.43 | 8.52 | 7.93 | 1.368 times |
26 Fri Jul 2024 | 8.56 | 8.53 | 8.70 | 8.34 | 1.786 times |
25 Thu Jul 2024 | 8.34 | 8.30 | 8.65 | 8.19 | 1.469 times |
24 Wed Jul 2024 | 8.16 | 8.45 | 8.54 | 8.09 | 0.479 times |
23 Tue Jul 2024 | 8.52 | 8.11 | 8.68 | 8.09 | 1.068 times |
22 Mon Jul 2024 | 8.13 | 7.93 | 8.20 | 7.79 | 0.579 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 7.7, but if it comes above 7.7, then a intra day buy could be more profitable.
If you take a sell trade below 7.7, then use 7.7 as stoploss and 7.1 as target. However if you take a buy trade in stock , then use 7.7 as stoploss and 8.15 as target.
Share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Target | 6.65 |
Downside Target | 6.80 |
Downside Target | 7.23 |
Upside Target | 7.38 |
Upside Target | 7.75 |
Upside Target | 8.52 |
Upside Target | 8.70 |
Upside Target | 8.82 |
Upside Target | 9.12 |
Upside Target | 9.25 |
Upside Target | 12.85 |
Intraday share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Intraday Target | 6.7 |
Downside Intraday Target | 6.07 |
Upside Intraday Target | 8.24 |
Upside Intraday Target | 9.15 |
Upside Intraday Target | 7.61 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
Date | Weekly Closing Price | Open | High | Low | Volume |
02 Fri Aug 2024 | 7.33 | 8.43 | 8.52 | 6.98 | 0.99 times |
26 Fri Jul 2024 | 8.56 | 7.93 | 8.70 | 7.79 | 0.822 times |
19 Fri Jul 2024 | 7.96 | 8.73 | 9.25 | 7.90 | 0.807 times |
12 Fri Jul 2024 | 8.78 | 7.37 | 8.82 | 7.23 | 5.391 times |
05 Fri Jul 2024 | 7.32 | 7.12 | 7.38 | 6.93 | 0.879 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
Date | Monthly Closing Price | Open | High | Low | Volume |
02 Fri Aug 2024 | 7.33 | 7.75 | 7.75 | 6.98 | 0.093 times |
31 Wed Jul 2024 | 7.75 | 7.37 | 9.25 | 6.93 | 0.924 times |
28 Fri Jun 2024 | 7.38 | 7.07 | 8.00 | 6.65 | 0.835 times |
31 Fri May 2024 | 7.07 | 8.93 | 9.12 | 6.80 | 0.678 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term but the sell signal is initial and weak.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.02 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term but the sell signal is initial and weak.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.02 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.